Publications
- Assessment of Incidence and Character of Neurologic/Neuropsychiatric Complications in a Group of Patients with Malignant Melanoma Treated with Adjuvant High Dose interferon2018 | Central Library of Charles University
- Non-specific immunotherapy inhibits angiogenesis - results of the monitoring of serum levels of vascular endothelial growth factor and matrix metalloproteinase 8 in patients with malignant melanoma receiving adjuvant high-dose interferon therapy2017 | First Faculty of Medicine, Central Library of Charles University
- High-dose Interferon Alpha in Treatment of Patients with Malignant Melanoma, Monitoring of Predictive and Prognostic Biomarkers2011 | Faculty of Medicine in Hradec Králové
- Prevention, diagnosis and treatment of cancer-associated thromboembolism2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Percutaneous CT-guided Biopsy of Focal Liver Lesions-Long-term Experience with more than 300 Procedures2023 | Faculty of Medicine in Hradec Králové, Faculty of Education
- Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
Loading network view...